TipRanks
Go Ultimate55% OFF

Turning Point Brands (0T5) AI Stock Analysis

0 Followers
DE:0T5

Turning Point Brands

(Frankfurt:0T5)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Modern Oral GrowthRapid Modern Oral growth is shifting TPB toward a category with expanding consumer adoption and increasing revenue contribution. The momentum, supported by broader retail distribution and direct-to-consumer channels, can strengthen scale, brand visibility, and future earnings power over the next several quarters.
Negative Factors
Weak Cash ConversionCash generation is currently weak relative to reported earnings, which may indicate working-capital or timing pressure. If this persists, TPB could have less internally generated funding for growth initiatives and reduced flexibility to absorb operating volatility or regulatory spending.

Turning Point Brands (0T5) vs. iShares MSCI Germany ETF (EWG)

-60%-40%-20%0%20%40%DE:0T5-27.71%EWG+3.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 1.35B
Dividend Yield
0.46%
Average Volume (3M)
30
Price to Earnings (P/E)
28.3
Beta (1Y)
0.78
Revenue Growth
12.11%
EPS Growth
-9.46%
Country
Germany
Employees
484
Sector
Consumer Defensive
Sector Strength
62
Industry
Tobacco

Turning Point Brands Business Overview & Revenue Model

Company Description

Turning Point Brands, Inc., along with its affiliated companies, is engaged in the creation, promotion, and distribution of a diverse array of branded consumer products. Its operations are structured into three distinct divisions: Zig-Zag Products, S...

Turning Point Brands Earnings Call Summary

Earnings Call Date:Aug 03, 2026(Q2-2026)|% Change Since:-3.45%|Next Earnings Date:Nov 08, 2026
Earnings Call SentimentPositive

The call was strongly optimistic, led by substantial Modern Oral growth, raised Modern Oral revenue guidance, expanding retail distribution, positive ALP traction, and continued investment in long-term brand and manufacturing capabilities. These positives outweighed lower adjusted EBITDA, higher SG&A, Zig-Zag softness, lower heritage revenue, reduced Stoker's gross margin, and PMTA timing uncertainty.

Positive Updates

Strong Modern Oral Growth
Modern Oral gross sales increased 149% year-over-year and 26% sequentially, while net sales increased 128% year-over-year and 32% sequentially. Growth was driven by expanded retail distribution for FRE and ALP and direct-to-consumer platforms.

Negative Updates

Adjusted EBITDA Decline
Adjusted EBITDA declined 50% year-over-year to $15 million, representing an 11% margin. The decline was attributed to increased sales and marketing investment and softness in Zig-Zag, partially offset by accelerated Modern Oral growth.

Company Guidance

Guidance calls for chain store count to increase 70% year-over-year by the end of 2026, sales force growth of approximately 50% this year, and, subject to regulatory approval, U.S. manufacturing to launch by the end of the year; once fully scaled, the company believes it can achieve gross margins of approximately 70%. Full year 2026 Modern Oral gross sales guidance is $330 million-$350 million, up from $280 million-$300 million, and net sales guidance is $260 million-$270 million, up from $210 million-$225 million; full-year EBITDA guidance remains $70 million-$90 million, inclusive of increased nicotine pouch investments, budgeted 2026 CapEx remains $4 million-$5 million, excluding projects related to Modern Oral, and the company expects to spend an additional $3 million-$5 million in 2026 in support of its PMTA applications.

Turning Point Brands Risk Analysis

Turning Point Brands disclosed 46 risk factors in its most recent earnings report. Turning Point Brands reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Turning Point Brands Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

DE:0T5 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
RLXRLX78Outperform$2.00B13.486.20%6.79%59.23%39.66%
BTIBTI68Neutral$134.19B16.1513.38%5.27%4.47%117.22%
PMPM68Neutral$329.31B29.42-119.68%2.98%7.91%24.06%
MOMO65Neutral$129.76B16.03-279.72%5.53%2.41%-7.63%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
XXIIXXII40Underperform$46.78M0.00-20.47%―-27.44%99.95%

* Consumer Defensive Sector Average

Performance Comparison

-100%-50%0%DE:0T5MOBTIPMXXIIRLXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:0T5 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:0T5Turning Point Brands Inc62.30-24.88-28.53%
MOAltria76.1222.2241.21%
BTIBritish American Tobacco60.898.5816.41%
PMPhilip Morris International197.8848.1132.12%
XXII22nd Century Group1.55-22444.45-99.99%
RLXRlx Technology, Inc.1.61-0.60-27.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.